Global and Japan Stem Cell Therapy for Osteoarthritis Market Size, Status and Forecast 2021-2028
Summary:
OA is the most common degenerative joint disease. Its initial symptoms include loss of articular cartilage followed by progressive to joint stiffness, swelling, pain, and loss of mobility.
Stem cells are the body's raw materials — cells from which all other cells with specialized functions are generated. Under the right conditions in the body or a laboratory, stem cells divide to form more cells called daughter cells. These daughter cells either become new stem cells (self-renewal) or become specialized cells (differentiation) with a more specific function, such as blood cells, brain cells, heart muscle cells or bone cells. No other cell in the body has the natural ability to generate new cell types.
Most stem cells used for the experimental treatment of OA are adult MSCs. Researchers can easily collect them from fat or bone marrow. MSCs are able to turn into cartilage, bone, muscle, tendon, ligaments, or fat, depending on the type of tissue that surrounds them. This is why researchers are studying MSCs in stem cell treatments for OA.
In the global market, the core manufacturers of Stem cell therapy for osteoarthritis include Medipost etc, and the top 1 manufacturer accounts for about 80% of the market share. The market include Asia Pacific and Europe, with a share of 90% and 10%. allogeneic accounted for 90% and autologous accounted for 10%. the product is mainly used in primary osteoarthritis and secondary osteoarthritis fields, with a share of 92% and 8%.
Market Snapshot
A recently published report by QY Research, titled “Global Stem Cell Therapy for Osteoarthritis Market Size, Status and Forecast 2022” gives an overview of the overall Stem Cell Therapy for Osteoarthritis market. This section sheds light on key impact-rendering drivers and constraints that are impacting the growth. It permits users to understand the different shortcomings and how they may hamper the development afterward. This segment is considered to be one of the most crucial segments of the report as it helps readers comprehend the impact of various macro and microeconomic factors on development. The role of various sectors, including small-scale and large-scale, in the expansion has also been discussed in the report. Additionally, the industry experts have put forth the current trends and prospects, which are likely to aid the growth in the upcoming years.
The global Stem Cell Therapy for Osteoarthritis market size is projected to reach US$ 84 million by 2027, from US$ 18 million in 2020, at a CAGR of 25.1% during 2021-2027.
Impact of Covid-19 Outbreak
This section of the report has explored the overall status of the Covid scenario and has offered valuable insights into the changes in supply chain disruption, fluctuations in demand, etc. The analysts have also focused on the key measures that the companies are opting to withstand the harsh scenario.
Segmental Analysis
The report has been segmented into product and application segments. The researchers have documented all the products present today in the Stem Cell Therapy for Osteoarthritis market. They have also shed light on the new product innovations and launches by the key players. In the segmental analysis, the analysts have provided revenue forecast figures based on type and application for the period 2016-2027. They have also discussed about the growth rate and potential of each segment for the period 2016-2027.
Stem Cell Therapy for Osteoarthritis Breakdown Data by Type
Allogeneic
Autologous
Stem Cell Therapy for Osteoarthritis Breakdown Data by Application
Primary Osteoarthritis
Secondary Osteoarthritis
Regional Analysis
The significant regions that are studied in the research report encompass North America, Europe, Asia Pacific, Central and South America, and the Middle East and Africa. In this section of the report, the specialists have explored various areas that are contributing to the development and can present lucrative growth prospects for the manufacturers in the forthcoming years. The report also provides region-wise and country-wise sales and revenue forecast data for the period 2021-2027.
Competitive Landscape
This segment focuses on the key players operating in the industry. It underlines all the current and future activities by the prominent manufacturers. By understanding various initiatives being taken up by different players, readers will gain the ability to settle on correct business choices. The authors of the report have provided accurate revenue figures of the companies for the period 2016-2021. The clients are sure to gain the upper hand once they get hold of this report. Key players studied in the research report include:
Medipost
Nature Cell
Theracell Advanced Biotechnology
Takeda (TiGenix)
Frequently Asked Questions
What factors will challenge the Stem Cell Therapy for Osteoarthritis market growth?
Which end-use segment will expand at the fastest CAGR in the Stem Cell Therapy for Osteoarthritis market?
Which are the emerging players in the Stem Cell Therapy for Osteoarthritis market?
How concentrated is the Stem Cell Therapy for Osteoarthritis market?
Which factors are positively contributing to the Stem Cell Therapy for Osteoarthritis market growth?
Which are the novel product innovations in the Stem Cell Therapy for Osteoarthritis market?
Which product segment will emerge as the most lucrative in the Stem Cell Therapy for Osteoarthritis market?
Which factors are increasing the competition in the Stem Cell Therapy for Osteoarthritis market?
Which are the strategic measures taken by the Stem Cell Therapy for Osteoarthritis industry players?
Which region will witness inactive growth during the forecast period?
Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Stem Cell Therapy for Osteoarthritis Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Allogeneic
1.2.3 Autologous
1.3 Market by Application
1.3.1 Global Stem Cell Therapy for Osteoarthritis Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Primary Osteoarthritis
1.3.3 Secondary Osteoarthritis
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Stem Cell Therapy for Osteoarthritis Market Perspective (2016-2027)
2.2 Stem Cell Therapy for Osteoarthritis Growth Trends by Regions
2.2.1 Stem Cell Therapy for Osteoarthritis Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Stem Cell Therapy for Osteoarthritis Historic Market Share by Regions (2016-2021)
2.2.3 Stem Cell Therapy for Osteoarthritis Forecasted Market Size by Regions (2022-2027)
2.3 Stem Cell Therapy for Osteoarthritis Industry Dynamic
2.3.1 Stem Cell Therapy for Osteoarthritis Market Trends
2.3.2 Stem Cell Therapy for Osteoarthritis Market Drivers
2.3.3 Stem Cell Therapy for Osteoarthritis Market Challenges
2.3.4 Stem Cell Therapy for Osteoarthritis Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Stem Cell Therapy for Osteoarthritis Players by Revenue
3.1.1 Global Top Stem Cell Therapy for Osteoarthritis Players by Revenue (2016-2021)
3.1.2 Global Stem Cell Therapy for Osteoarthritis Revenue Market Share by Players (2016-2021)
3.2 Global Stem Cell Therapy for Osteoarthritis Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Stem Cell Therapy for Osteoarthritis Revenue
3.4 Global Stem Cell Therapy for Osteoarthritis Market Concentration Ratio
3.4.1 Global Stem Cell Therapy for Osteoarthritis Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Stem Cell Therapy for Osteoarthritis Revenue in 2020
3.5 Stem Cell Therapy for Osteoarthritis Key Players Head office and Area Served
3.6 Key Players Stem Cell Therapy for Osteoarthritis Product Solution and Service
3.7 Date of Enter into Stem Cell Therapy for Osteoarthritis Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Stem Cell Therapy for Osteoarthritis Breakdown Data by Type
4.1 Global Stem Cell Therapy for Osteoarthritis Historic Market Size by Type (2016-2021)
4.2 Global Stem Cell Therapy for Osteoarthritis Forecasted Market Size by Type (2022-2027)
5 Stem Cell Therapy for Osteoarthritis Breakdown Data by Application
5.1 Global Stem Cell Therapy for Osteoarthritis Historic Market Size by Application (2016-2021)
5.2 Global Stem Cell Therapy for Osteoarthritis Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Stem Cell Therapy for Osteoarthritis Market Size (2016-2027)
6.2 North America Stem Cell Therapy for Osteoarthritis Market Size by Type
6.2.1 North America Stem Cell Therapy for Osteoarthritis Market Size by Type (2016-2021)
6.2.2 North America Stem Cell Therapy for Osteoarthritis Market Size by Type (2022-2027)
6.2.3 North America Stem Cell Therapy for Osteoarthritis Market Size by Type (2016-2027)
6.3 North America Stem Cell Therapy for Osteoarthritis Market Size by Application
6.3.1 North America Stem Cell Therapy for Osteoarthritis Market Size by Application (2016-2021)
6.3.2 North America Stem Cell Therapy for Osteoarthritis Market Size by Application (2022-2027)
6.3.3 North America Stem Cell Therapy for Osteoarthritis Market Size by Application (2016-2027)
6.4 North America Stem Cell Therapy for Osteoarthritis Market Size by Country
6.4.1 North America Stem Cell Therapy for Osteoarthritis Market Size by Country (2016-2021)
6.4.2 North America Stem Cell Therapy for Osteoarthritis Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Stem Cell Therapy for Osteoarthritis Market Size (2016-2027)
7.2 Europe Stem Cell Therapy for Osteoarthritis Market Size by Type
7.2.1 Europe Stem Cell Therapy for Osteoarthritis Market Size by Type (2016-2021)
7.2.2 Europe Stem Cell Therapy for Osteoarthritis Market Size by Type (2022-2027)
7.2.3 Europe Stem Cell Therapy for Osteoarthritis Market Size by Type (2016-2027)
7.3 Europe Stem Cell Therapy for Osteoarthritis Market Size by Application
7.3.1 Europe Stem Cell Therapy for Osteoarthritis Market Size by Application (2016-2021)
7.3.2 Europe Stem Cell Therapy for Osteoarthritis Market Size by Application (2022-2027)
7.3.3 Europe Stem Cell Therapy for Osteoarthritis Market Size by Application (2016-2027)
7.4 Europe Stem Cell Therapy for Osteoarthritis Market Size by Country
7.4.1 Europe Stem Cell Therapy for Osteoarthritis Market Size by Country (2016-2021)
7.4.2 Europe Stem Cell Therapy for Osteoarthritis Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Stem Cell Therapy for Osteoarthritis Market Size (2016-2027)
8.2 Asia-Pacific Stem Cell Therapy for Osteoarthritis Market Size by Type
8.2.1 Asia-Pacific Stem Cell Therapy for Osteoarthritis Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Stem Cell Therapy for Osteoarthritis Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Stem Cell Therapy for Osteoarthritis Market Size by Type (2016-2027)
8.3 Asia-Pacific Stem Cell Therapy for Osteoarthritis Market Size by Application
8.3.1 Asia-Pacific Stem Cell Therapy for Osteoarthritis Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Stem Cell Therapy for Osteoarthritis Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Stem Cell Therapy for Osteoarthritis Market Size by Application (2016-2027)
8.4 Asia-Pacific Stem Cell Therapy for Osteoarthritis Market Size by Region
8.4.1 Asia-Pacific Stem Cell Therapy for Osteoarthritis Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Stem Cell Therapy for Osteoarthritis Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Stem Cell Therapy for Osteoarthritis Market Size (2016-2027)
9.2 Latin America Stem Cell Therapy for Osteoarthritis Market Size by Type
9.2.1 Latin America Stem Cell Therapy for Osteoarthritis Market Size by Type (2016-2021)
9.2.2 Latin America Stem Cell Therapy for Osteoarthritis Market Size by Type (2022-2027)
9.2.3 Latin America Stem Cell Therapy for Osteoarthritis Market Size by Type (2016-2027)
9.3 Latin America Stem Cell Therapy for Osteoarthritis Market Size by Application
9.3.1 Latin America Stem Cell Therapy for Osteoarthritis Market Size by Application (2016-2021)
9.3.2 Latin America Stem Cell Therapy for Osteoarthritis Market Size by Application (2022-2027)
9.3.3 Latin America Stem Cell Therapy for Osteoarthritis Market Size by Application (2016-2027)
9.4 Latin America Stem Cell Therapy for Osteoarthritis Market Size by Country
9.4.1 Latin America Stem Cell Therapy for Osteoarthritis Market Size by Country (2016-2021)
9.4.2 Latin America Stem Cell Therapy for Osteoarthritis Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Stem Cell Therapy for Osteoarthritis Market Size (2016-2027)
10.2 Middle East & Africa Stem Cell Therapy for Osteoarthritis Market Size by Type
10.2.1 Middle East & Africa Stem Cell Therapy for Osteoarthritis Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Stem Cell Therapy for Osteoarthritis Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Stem Cell Therapy for Osteoarthritis Market Size by Type (2016-2027)
10.3 Middle East & Africa Stem Cell Therapy for Osteoarthritis Market Size by Application
10.3.1 Middle East & Africa Stem Cell Therapy for Osteoarthritis Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Stem Cell Therapy for Osteoarthritis Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Stem Cell Therapy for Osteoarthritis Market Size by Application (2016-2027)
10.4 Middle East & Africa Stem Cell Therapy for Osteoarthritis Market Size by Country
10.4.1 Middle East & Africa Stem Cell Therapy for Osteoarthritis Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Stem Cell Therapy for Osteoarthritis Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Medipost
11.1.1 Medipost Company Details
11.1.2 Medipost Business Overview
11.1.3 Medipost Stem Cell Therapy for Osteoarthritis Introduction
11.1.4 Medipost Revenue in Stem Cell Therapy for Osteoarthritis Business (2016-2021)
11.1.5 Medipost Recent Development
11.2 Nature Cell
11.2.1 Nature Cell Company Details
11.2.2 Nature Cell Business Overview
11.2.3 Nature Cell Stem Cell Therapy for Osteoarthritis Introduction
11.2.4 Nature Cell Revenue in Stem Cell Therapy for Osteoarthritis Business (2016-2021)
11.2.5 Nature Cell Recent Development
11.3 Theracell Advanced Biotechnology
11.3.1 Theracell Advanced Biotechnology Company Details
11.3.2 Theracell Advanced Biotechnology Business Overview
11.3.3 Theracell Advanced Biotechnology Stem Cell Therapy for Osteoarthritis Introduction
11.3.4 Theracell Advanced Biotechnology Revenue in Stem Cell Therapy for Osteoarthritis Business (2016-2021)
11.3.5 Theracell Advanced Biotechnology Recent Development
11.4 Takeda (TiGenix)
11.4.1 Takeda (TiGenix) Company Details
11.4.2 Takeda (TiGenix) Business Overview
11.4.3 Takeda (TiGenix) Stem Cell Therapy for Osteoarthritis Introduction
11.4.4 Takeda (TiGenix) Revenue in Stem Cell Therapy for Osteoarthritis Business (2016-2021)
11.4.5 Takeda (TiGenix) Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Tables and Figures
List of Tables
Table 1. Global Stem Cell Therapy for Osteoarthritis Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Allogeneic
Table 3. Key Players of Autologous
Table 4. Global Stem Cell Therapy for Osteoarthritis Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 5. Global Stem Cell Therapy for Osteoarthritis Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Stem Cell Therapy for Osteoarthritis Market Size by Regions (2016-2021) & (US$ Million)
Table 7. Global Stem Cell Therapy for Osteoarthritis Market Share by Regions (2016-2021)
Table 8. Global Stem Cell Therapy for Osteoarthritis Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 9. Global Stem Cell Therapy for Osteoarthritis Market Share by Regions (2022-2027)
Table 10. Stem Cell Therapy for Osteoarthritis Market Trends
Table 11. Stem Cell Therapy for Osteoarthritis Market Drivers
Table 12. Stem Cell Therapy for Osteoarthritis Market Challenges
Table 13. Stem Cell Therapy for Osteoarthritis Market Restraints
Table 14. Global Stem Cell Therapy for Osteoarthritis Revenue by Players (2016-2021) & (US$ Million)
Table 15. Global Stem Cell Therapy for Osteoarthritis Market Share by Players (2016-2021)
Table 16. Global Top Stem Cell Therapy for Osteoarthritis Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Stem Cell Therapy for Osteoarthritis as of 2020)
Table 17. Ranking of Global Top Stem Cell Therapy for Osteoarthritis Companies by Revenue (US$ Million) in 2020
Table 18. Global 5 Largest Players Market Share by Stem Cell Therapy for Osteoarthritis Revenue (CR5 and HHI) & (2016-2021)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Stem Cell Therapy for Osteoarthritis Product Solution and Service
Table 21. Date of Enter into Stem Cell Therapy for Osteoarthritis Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Stem Cell Therapy for Osteoarthritis Market Size by Type (2016-2021) (US$ Million)
Table 24. Global Stem Cell Therapy for Osteoarthritis Revenue Market Share by Type (2016-2021)
Table 25. Global Stem Cell Therapy for Osteoarthritis Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 26. Global Stem Cell Therapy for Osteoarthritis Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 27. Global Stem Cell Therapy for Osteoarthritis Market Size Share by Application (2016-2021) & (US$ Million)
Table 28. Global Stem Cell Therapy for Osteoarthritis Revenue Market Share by Application (2016-2021)
Table 29. Global Stem Cell Therapy for Osteoarthritis Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 30. Global Stem Cell Therapy for Osteoarthritis Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 31. North America Stem Cell Therapy for Osteoarthritis Market Size by Type (2016-2021) (US$ Million)
Table 32. North America Stem Cell Therapy for Osteoarthritis Market Size by Type (2022-2027) & (US$ Million)
Table 33. North America Stem Cell Therapy for Osteoarthritis Market Size by Application (2016-2021) (US$ Million)
Table 34. North America Stem Cell Therapy for Osteoarthritis Market Size by Application (2022-2027) & (US$ Million)
Table 35. North America Stem Cell Therapy for Osteoarthritis Market Size by Country (2016-2021) & (US$ Million)
Table 36. North America Stem Cell Therapy for Osteoarthritis Market Size by Country (2022-2027) & (US$ Million)
Table 37. Europe Stem Cell Therapy for Osteoarthritis Market Size by Type (2016-2021) (US$ Million)
Table 38. Europe Stem Cell Therapy for Osteoarthritis Market Size by Type (2022-2027) & (US$ Million)
Table 39. Europe Stem Cell Therapy for Osteoarthritis Market Size by Application (2016-2021) (US$ Million)
Table 40. Europe Stem Cell Therapy for Osteoarthritis Market Size by Application (2022-2027) & (US$ Million)
Table 41. Europe Stem Cell Therapy for Osteoarthritis Market Size by Country (2016-2021) & (US$ Million)
Table 42. Europe Stem Cell Therapy for Osteoarthritis Market Size by Country (2022-2027) & (US$ Million)
Table 43. Asia-Pacific Stem Cell Therapy for Osteoarthritis Market Size by Type (2016-2021) (US$ Million)
Table 44. Asia-Pacific Stem Cell Therapy for Osteoarthritis Market Size by Type (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Stem Cell Therapy for Osteoarthritis Market Size by Application (2016-2021) (US$ Million)
Table 46. Asia-Pacific Stem Cell Therapy for Osteoarthritis Market Size by Application (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Stem Cell Therapy for Osteoarthritis Market Size by Region (2016-2021) & (US$ Million)
Table 48. Asia-Pacific Stem Cell Therapy for Osteoarthritis Market Size by Region (2022-2027) & (US$ Million)
Table 49. Latin America Stem Cell Therapy for Osteoarthritis Market Size by Type (2016-2021) (US$ Million)
Table 50. Latin America Stem Cell Therapy for Osteoarthritis Market Size by Type (2022-2027) & (US$ Million)
Table 51. Latin America Stem Cell Therapy for Osteoarthritis Market Size by Application (2016-2021) (US$ Million)
Table 52. Latin America Stem Cell Therapy for Osteoarthritis Market Size by Application (2022-2027) & (US$ Million)
Table 53. Latin America Stem Cell Therapy for Osteoarthritis Market Size by Country (2016-2021) & (US$ Million)
Table 54. Latin America Stem Cell Therapy for Osteoarthritis Market Size by Country (2022-2027) & (US$ Million)
Table 55. Middle East & Africa Stem Cell Therapy for Osteoarthritis Market Size by Type (2016-2021) (US$ Million)
Table 56. Middle East & Africa Stem Cell Therapy for Osteoarthritis Market Size by Type (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Stem Cell Therapy for Osteoarthritis Market Size by Application (2016-2021) (US$ Million)
Table 58. Middle East & Africa Stem Cell Therapy for Osteoarthritis Market Size by Application (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Stem Cell Therapy for Osteoarthritis Market Size by Country (2016-2021) & (US$ Million)
Table 60. Middle East & Africa Stem Cell Therapy for Osteoarthritis Market Size by Country (2022-2027) & (US$ Million)
Table 61. Medipost Company Details
Table 62. Medipost Business Overview
Table 63. Medipost Stem Cell Therapy for Osteoarthritis Product
Table 64. Medipost Revenue in Stem Cell Therapy for Osteoarthritis Business (2016-2021) & (US$ Million)
Table 65. Medipost Recent Development
Table 66. Nature Cell Company Details
Table 67. Nature Cell Business Overview
Table 68. Nature Cell Stem Cell Therapy for Osteoarthritis Product
Table 69. Nature Cell Revenue in Stem Cell Therapy for Osteoarthritis Business (2016-2021) & (US$ Million)
Table 70. Nature Cell Recent Development
Table 71. Theracell Advanced Biotechnology Company Details
Table 72. Theracell Advanced Biotechnology Business Overview
Table 73. Theracell Advanced Biotechnology Stem Cell Therapy for Osteoarthritis Product
Table 74. Theracell Advanced Biotechnology Revenue in Stem Cell Therapy for Osteoarthritis Business (2016-2021) & (US$ Million)
Table 75. Theracell Advanced Biotechnology Recent Development
Table 76. Takeda (TiGenix) Company Details
Table 77. Takeda (TiGenix) Business Overview
Table 78. Takeda (TiGenix) Stem Cell Therapy for Osteoarthritis Product
Table 79. Takeda (TiGenix) Revenue in Stem Cell Therapy for Osteoarthritis Business (2016-2021) & (US$ Million)
Table 80. Takeda (TiGenix) Recent Development
Table 81. Research Programs/Design for This Report
Table 82. Key Data Information from Secondary Sources
Table 83. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Stem Cell Therapy for Osteoarthritis Market Share by Type: 2020 VS 2027
Figure 2. Allogeneic Features
Figure 3. Autologous Features
Figure 4. Global Stem Cell Therapy for Osteoarthritis Market Share by Application: 2020 VS 2027
Figure 5. Primary Osteoarthritis Case Studies
Figure 6. Secondary Osteoarthritis Case Studies
Figure 7. Stem Cell Therapy for Osteoarthritis Report Years Considered
Figure 8. Global Stem Cell Therapy for Osteoarthritis Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 9. Global Stem Cell Therapy for Osteoarthritis Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 10. Global Stem Cell Therapy for Osteoarthritis Market Share by Regions: 2020 VS 2027
Figure 11. Global Stem Cell Therapy for Osteoarthritis Market Share by Regions (2022-2027)
Figure 12. Global Stem Cell Therapy for Osteoarthritis Market Share by Players in 2020
Figure 13. Global Top Stem Cell Therapy for Osteoarthritis Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Stem Cell Therapy for Osteoarthritis as of 2020
Figure 14. The Top 10 and 5 Players Market Share by Stem Cell Therapy for Osteoarthritis Revenue in 2020
Figure 15. Global Stem Cell Therapy for Osteoarthritis Revenue Market Share by Type (2016-2021)
Figure 16. Global Stem Cell Therapy for Osteoarthritis Revenue Market Share by Type (2022-2027)
Figure 17. North America Stem Cell Therapy for Osteoarthritis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 18. North America Stem Cell Therapy for Osteoarthritis Market Share by Type (2016-2027)
Figure 19. North America Stem Cell Therapy for Osteoarthritis Market Share by Application (2016-2027)
Figure 20. North America Stem Cell Therapy for Osteoarthritis Market Share by Country (2016-2027)
Figure 21. United States Stem Cell Therapy for Osteoarthritis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 22. Canada Stem Cell Therapy for Osteoarthritis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 23. Europe Stem Cell Therapy for Osteoarthritis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Europe Stem Cell Therapy for Osteoarthritis Market Share by Type (2016-2027)
Figure 25. Europe Stem Cell Therapy for Osteoarthritis Market Share by Application (2016-2027)
Figure 26. Europe Stem Cell Therapy for Osteoarthritis Market Share by Country (2016-2027)
Figure 27. Germany Stem Cell Therapy for Osteoarthritis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. France Stem Cell Therapy for Osteoarthritis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. U.K. Stem Cell Therapy for Osteoarthritis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. Italy Stem Cell Therapy for Osteoarthritis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. Russia Stem Cell Therapy for Osteoarthritis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Nordic Stem Cell Therapy for Osteoarthritis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Asia-Pacific Stem Cell Therapy for Osteoarthritis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Asia-Pacific Stem Cell Therapy for Osteoarthritis Market Share by Type (2016-2027)
Figure 35. Asia-Pacific Stem Cell Therapy for Osteoarthritis Market Share by Application (2016-2027)
Figure 36. Asia-Pacific Stem Cell Therapy for Osteoarthritis Market Share by Region (2016-2027)
Figure 37. China Stem Cell Therapy for Osteoarthritis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Japan Stem Cell Therapy for Osteoarthritis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. South Korea Stem Cell Therapy for Osteoarthritis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Southeast Asia Stem Cell Therapy for Osteoarthritis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. India Stem Cell Therapy for Osteoarthritis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Australia Stem Cell Therapy for Osteoarthritis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Latin America Stem Cell Therapy for Osteoarthritis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Latin America Stem Cell Therapy for Osteoarthritis Market Share by Type (2016-2027)
Figure 45. Latin America Stem Cell Therapy for Osteoarthritis Market Share by Application (2016-2027)
Figure 46. Latin America Stem Cell Therapy for Osteoarthritis Market Share by Country (2016-2027)
Figure 47. Mexico Stem Cell Therapy for Osteoarthritis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Brazil Stem Cell Therapy for Osteoarthritis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Middle East & Africa Stem Cell Therapy for Osteoarthritis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Middle East & Africa Stem Cell Therapy for Osteoarthritis Market Share by Type (2016-2027)
Figure 51. Middle East & Africa Stem Cell Therapy for Osteoarthritis Market Share by Application (2016-2027)
Figure 52. Middle East & Africa Stem Cell Therapy for Osteoarthritis Market Share by Country (2016-2027)
Figure 53. Turkey Stem Cell Therapy for Osteoarthritis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Saudi Arabia Stem Cell Therapy for Osteoarthritis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. UAE Stem Cell Therapy for Osteoarthritis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Medipost Revenue Growth Rate in Stem Cell Therapy for Osteoarthritis Business (2016-2021)
Figure 57. Nature Cell Revenue Growth Rate in Stem Cell Therapy for Osteoarthritis Business (2016-2021)
Figure 58. Theracell Advanced Biotechnology Revenue Growth Rate in Stem Cell Therapy for Osteoarthritis Business (2016-2021)
Figure 59. Takeda (TiGenix) Revenue Growth Rate in Stem Cell Therapy for Osteoarthritis Business (2016-2021)
Figure 60. Bottom-up and Top-down Approaches for This Report
Figure 61. Data Triangulation
Figure 62. Key Executives Interviewed
Reason to Buy
- Current and future of Pharma & Healthcare Market outlook in the developed and emerging markets
- Highlights key business priorities in order to assist companies to realign their business strategies
- The segment that is expected to dominate the Pharma & Healthcare Market
- Regions that are expected to witness the fastest growth during the forecast period
- Identify the latest developments, Pharma & Healthcare Market shares, and strategies employed by the major market players
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the global Pharma & Healthcare Market
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets